Advies- en ingenieursbureau WILMARC (Public limited company)
Advies- en ingenieursbureau WILMARC is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0421.789.949. It was founded on 11-08-1981. Its registered office is in Auderghem. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2024 report equity of € 1 834 621 and a loss of € 476 655. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2025 financial year have not been filed, although the legal deadline has passed.
Information last updated on 07-10-2026.
Company information
Key figures of Advies- en ingenieursbureau WILMARC
| 2024 | 2023 | 2022 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -476 655+17 % | € -577 376-8 % | € -535 955 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 1 834 621-21 % | € 2 311 277-20 % | € 2 888 653 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 19 385 932+9 % | € 17 807 223-1 % | € 17 915 785 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 542 756+24 % | € 437 283-17 % | € 526 696 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - |
Financial estimate
- 1 Shareholders
- 1 Board links
Similar companies
Other companies in the same activity in Auderghem.
| Company | Town |
|---|---|
| Billen | 1160 Auderghem |
| PHASIANUS | 1160 Auderghem |
| MIMOSAPHARMA | 1160 Auderghem |
| Technologies de la mer, de l'informatique et des communications | 1160 Auderghem |
| Pharmarota Service | 1160 Auderghem |
Frequently asked questions
Is Advies- en ingenieursbureau WILMARC still active? Yes. The Crossroads Bank for Enterprises lists Advies- en ingenieursbureau WILMARC as active.
What is the VAT number of Advies- en ingenieursbureau WILMARC? Advies- en ingenieursbureau WILMARC is not registered for VAT. Its enterprise number is 0421.789.949.
When was Advies- en ingenieursbureau WILMARC founded? Advies- en ingenieursbureau WILMARC was founded on 11-08-1981.
What is the address of Advies- en ingenieursbureau WILMARC? The current registered office of Advies- en ingenieursbureau WILMARC is Boulevard du Souverain 292, 1160 Auderghem.
When did Advies- en ingenieursbureau WILMARC last file annual accounts? The latest annual accounts of Advies- en ingenieursbureau WILMARC were filed on 22-10-2025.
Does Advies- en ingenieursbureau WILMARC file its annual accounts on time? The annual accounts of Advies- en ingenieursbureau WILMARC for the 2025 financial year have not been filed, although the legal deadline has passed.
Is Advies- en ingenieursbureau WILMARC financially healthy? Addrly gives Advies- en ingenieursbureau WILMARC a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Advies- en ingenieursbureau WILMARC profitable? The annual accounts of Advies- en ingenieursbureau WILMARC for 2024 show a loss of € 476 655.
What is the equity of Advies- en ingenieursbureau WILMARC? The equity of Advies- en ingenieursbureau WILMARC was € 1 834 621 at the close of the 2024 financial year.
Who are the directors of Advies- en ingenieursbureau WILMARC? The annual accounts of Advies- en ingenieursbureau WILMARC record 3 mandates. The names, roles and dates are visible with a free account.
Can Advies- en ingenieursbureau WILMARC receive Peppol e-invoices? Yes. Advies- en ingenieursbureau WILMARC is registered on the Peppol network and can receive structured electronic invoices.
What does Advies- en ingenieursbureau WILMARC do? The main activity of Advies- en ingenieursbureau WILMARC is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.